Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
申请人:——
公开号:US20020016334A1
公开(公告)日:2002-02-07
Pharmaceutical compositions are disclosed for the treatment of attention deficit hyperactivity disorder (ADHD). The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotine receptor partial agonist and an anti-ADHD agent and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.